• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Raptor Pharmaceutical Corp

+ Add to Watchlist

RPTP:US

8.7300 USD 0.3400 4.05%

As of 20:10:00 ET on 07/23/2014.

Snapshot for Raptor Pharmaceutical Corp (RPTP)

Open: 8.4600 Day's Range: 8.4500 - 8.8400 Volume: 427,179
Previous Close: 8.3900 52wk Range: 7.1200 - 17.7200 1-Yr Rtn: -14.33%

Stock Chart for RPTP

No chart data available.
  • RPTP:US 8.7300
  • 1D
  • 1M
  • 1Y
8.3900
Interactive RPTP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RPTP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.1598
Est. EPS (USD) (12/2014) -0.6840
Est. PEG Ratio -
Market Cap (M USD) 547.06
Shares Outstanding (M) 62.66
30 Day Average Volume 697,971
Price/Book (mrq) 20.4739
Price/Sale (ttm) 18.4702
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RPTP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RPTP

Raptor Pharmaceuticals Corporation provides medical research services. The Company develops, manufactures, and commercializes medicines and clinical treatment for neurodegenerative disorder and liver disease. Raptor Pharmaceuticals serves the medical field worldwide.

Christopher M StarrCEO/Co-FounderJulie Anne SmithPresident/CEO-Designate
Georgia ErbezCFO/Treasurer/SecretaryThomas E Daley "Ted"Chief Business Officer
More Company Profile & Key Executives for RPTP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil